MAFFICINI, Andrea
 Distribuzione geografica
Continente #
EU - Europa 5.080
NA - Nord America 4.580
AS - Asia 3.553
SA - Sud America 561
AF - Africa 75
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.866
Nazione #
US - Stati Uniti d'America 4.476
CN - Cina 1.466
GB - Regno Unito 1.466
SG - Singapore 1.212
RU - Federazione Russa 1.113
IT - Italia 715
BR - Brasile 495
HK - Hong Kong 388
DE - Germania 378
SE - Svezia 340
IE - Irlanda 299
FR - Francia 267
FI - Finlandia 216
VN - Vietnam 113
KR - Corea 100
CA - Canada 61
NL - Olanda 56
UA - Ucraina 47
IN - India 45
BE - Belgio 39
AT - Austria 37
JP - Giappone 37
TR - Turchia 34
MX - Messico 32
ES - Italia 31
ID - Indonesia 30
AR - Argentina 26
PL - Polonia 21
TG - Togo 20
ZA - Sudafrica 20
BD - Bangladesh 18
IQ - Iraq 16
IR - Iran 16
UZ - Uzbekistan 14
MA - Marocco 11
AU - Australia 10
EC - Ecuador 10
NO - Norvegia 9
LT - Lituania 8
LV - Lettonia 8
PK - Pakistan 8
KG - Kirghizistan 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
IL - Israele 6
PE - Perù 6
SA - Arabia Saudita 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
JO - Giordania 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
EG - Egitto 4
KE - Kenya 4
NZ - Nuova Zelanda 4
AL - Albania 3
DO - Repubblica Dominicana 3
EU - Europa 3
KZ - Kazakistan 3
LK - Sri Lanka 3
TW - Taiwan 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
IS - Islanda 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MW - Malawi 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 13.866
Città #
Southend 1.322
Dallas 679
Chandler 664
Singapore 493
Hong Kong 385
Ashburn 316
Woodbridge 316
Verona 296
Dublin 279
Beijing 267
Moscow 264
Ann Arbor 259
Jacksonville 241
New York 169
Munich 127
Jinan 101
Shenyang 98
Los Angeles 89
Lawrence 87
Princeton 87
Houston 76
Nanjing 76
Wilmington 75
The Dalles 69
Hebei 57
Helsinki 55
Turku 53
Redondo Beach 50
São Paulo 49
Tianjin 49
Zhengzhou 46
Changsha 42
Columbus 42
Redmond 42
Haikou 41
Brussels 39
Ningbo 38
Santa Clara 37
London 36
Hangzhou 35
Buffalo 34
Nanchang 34
Sindelfingen 34
Taizhou 34
Dong Ket 32
Seoul 31
Guangzhou 30
Seattle 28
Jiaxing 27
Lancaster 27
Shanghai 26
Brescia 25
Vienna 25
Tokyo 24
Ho Chi Minh City 21
Jakarta 21
Milan 21
Taiyuan 21
Lomé 20
Nuremberg 20
Frankfurt am Main 19
Hanoi 19
Lanzhou 19
San Francisco 19
Toronto 19
Dearborn 18
Kent 18
Rome 18
Stockholm 18
Council Bluffs 17
Lappeenranta 17
Belo Horizonte 16
Johannesburg 16
Mexico City 16
Montreal 16
Bologna 15
Brooklyn 15
Norwalk 15
Redwood City 15
Boardman 14
Madrid 14
Rio de Janeiro 14
Tashkent 14
Warsaw 14
Chicago 13
Falkenstein 13
Washington 13
Amsterdam 12
Chennai 12
Curitiba 12
Falls Church 12
Poplar 11
Fairfield 10
Fuzhou 10
Goiânia 9
Orem 9
Ankara 8
Auburn Hills 8
Charlotte 8
Padova 8
Totale 8.644
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 283
Whole-genome landscape of pancreatic neuroendocrine tumours 228
Nuovi approcci proteomici per l'identificazione di potenziali marcatori di neoplasie pancreatiche 216
Characterization of new monoclonal antibodies specific for the extracellular domain of PTPRG, a candidate tumour suppressor gene 213
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 210
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 204
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 202
Genomic characterization of hepatoid tumors: context matters 199
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 193
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 183
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 183
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 182
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 179
MONOCLONAL ANTIBODY FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA 179
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 178
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 178
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 176
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 173
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 170
Urokinase Plasminogen Activator Receptor Could Be a New UsefulMarker in Pancreatic Cancer and Appears to Be Related to Survival 162
Expression of transmembrane protein tyrosine phosphatase gamma (Ptpgamma) in normal and neoplastic human tissues. 162
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 159
Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues 156
Reporting tumor molecular heterogeneity in histopathological diagnosis 156
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 154
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 152
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 150
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 150
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 150
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 148
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 146
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 146
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 143
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 143
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 141
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes 140
Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. 139
Splice variants as novel targets in pancreatic ductal adenocarcinoma 138
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 138
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 137
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 136
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 135
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 134
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium 134
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 134
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 133
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 133
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 132
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 131
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 126
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer 126
Comparative Lesions Analysis Through a Targeted Sequencing Approach 126
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 126
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 126
Pancreatic cancer genomics 125
Fhit down-regulation is an early event in pancreatic carcinogenesis 124
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 121
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 120
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients 118
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 118
FrequentNRG1fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression 117
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 117
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 116
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 113
In situ analysis of methylarginine 113
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 108
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. 106
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 105
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 105
Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium 105
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 104
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 104
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 101
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 101
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 100
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 100
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 100
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin 100
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 98
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 93
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 88
Author Correction: The landscape of viral associations in human cancers 88
New genomic landscapes and therapeutic targets for biliary tract cancers 88
Receptor type tyrosine phosphatase gamma (PTP gamma) is a novel dendritic cell marker 87
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 86
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study 83
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 83
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities 79
Recurrent oligodendroglioma with changed 1p/19q status 79
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 77
Comprehensive molecular characterization of mitochondrial genomes in human cancers 76
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 76
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 75
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 75
Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy 74
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 73
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 73
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 72
Cerebellar mass in a 31-year-old woman 70
Non-coding regulatory variations: the dark matter of pancreatic cancer genomics 68
Totale 13.073
Categoria #
all - tutte 50.632
article - articoli 43.668
book - libri 0
conference - conferenze 5.658
curatela - curatele 0
other - altro 423
patent - brevetti 463
selected - selezionate 0
volume - volumi 420
Totale 101.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 89 49 15 30 36 22 64 65
2021/20221.067 93 329 54 75 59 24 33 66 33 29 77 195
2022/20231.800 115 233 143 297 157 445 14 126 202 11 30 27
2023/20241.117 48 71 72 101 117 223 46 119 16 73 184 47
2024/20253.090 127 142 173 473 185 143 201 153 399 184 343 567
2025/20263.315 572 484 709 1.425 125 0 0 0 0 0 0 0
Totale 14.097